Our Q&A videos help you make sense of the science, featuring questions from patients and caregivers answered by members of the scientific community.
Video Q&A Series
Dr. Tejas Patil, University of Colorado Cancer Center
Dr. Tejas Patil, University of Colorado Cancer Center
Dr. Tejas Patil, University of Colorado Cancer Center
Dr. John Heymach, M.D. Anderson Cancer Center
Dr. John Heymach, M.D. Anderson Cancer Center
Dr. John Heymach, M.D. Anderson Cancer Center
Dr. Jessica Lin, Massachusetts General Hospital
Jump to:
Why should patients consider participating in clinical trials?
What can we do to increase RET research?
Are there any new treatment options on the horizon for RET+NSCLC patients?
Why do non-smokers get lung cancer?
What are the newest RET inhibitors on the horizon?
What is the ultimate goal of the RETGistry and how can patients support their continued progress?
Why should patients consider participating in clinical trials?
Dr. Tejas Patil, University of Colorado Cancer Center
What can we do to increase RET research?
Dr. Tejas Patil, University of Colorado Cancer Center
Are there any new treatment options on the horizon for RET+NSCLC patients?
Dr. Tejas Patil, University of Colorado Cancer Center
Why do non-smokers get lung cancer?
Dr. John Heymach, M.D. Anderson Cancer Center
What are the newest RET inhibitors on the horizon?
Dr. John Heymach, M.D. Anderson Cancer Center
Explain the different mechanisms of resistance to RET therapies & strategies to target these mechanisms.
Dr. John Heymach, M.D. Anderson Cancer Center
What is the ultimate goal of the RETGistry and how can patients support their continued progress?
Dr. Jessica Lin, Massachusetts General Hospital
